“RP- HPLC Method Development And Validation For Estimation Of Dapagliflozin In Tablet Formulation”, Journal of Pharmaceutical Negative Results, vol. 13, pp. 364–372, Oct. 2022, doi: 10.47750/pnr.2022.13.S05.53.